Is Octamile profitable in 2026?

No public revenue or profitability data exists for 2024 to 2026. The last self-reported figure was around $642,100 in revenue with a 10-person team in 2023, and no confirmed funding or product news has surfaced since October 2023.

Has Octamile raised its Series A yet?

As of mid-2026 there is no public confirmation. In October 2023 Octamile said it was targeting a $2 million extension raise after roughly $600,000 raised previously, but no close has been announced in the nearly three years since.

Who is Octamile's biggest competitor?

Curacel, a Lagos-based AI-powered claims automation startup founded in 2019 and a Y Combinator W22 graduate backed by Tencent, is Octamile's most frequently cited direct rival and appears better capitalized as of September 2025.

Could AI replace Octamile's claims processing business?

Octamile's core workflows, first notification of loss, document extraction, rules-based decisioning, and vehicle valuation, are exactly what AI-native rivals like Curacel and global players such as FurtherAI and Poetic are automating as of 2025 to 2026.

Octamile is a private, venture-backed Nigerian startup founded by CEO Gbenro Dara, a former Jumia, Hotels.ng, Cheki and Opera/OList executive, with no known parent company as of the most recent available data in 2023.

What licenses or partnerships give Octamile an edge in Nigeria?

Octamile holds NAICOM-related regulatory relationships and embedded partnerships with Gokada, Treepz, FirstBank and AXA Mansard, including an October 2023 Treepz Care insurance launch, giving it local integration lock-in that pure AI models lack.

Insurance technology companies · Unknown

Octamile

Octamile embeds insurance into rides, deliveries, and banking apps in Nigeria.

Little protection left

Assessed 23 July 2026 · Evidence as of 23 July 2026

Not much stands between this business and its pressures.

On the recordSince 23 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Confirmation (or continued absence) of the $2M extension round announced in October 2023

The call

Octamile built real local plumbing but has gone quiet for two years while better-funded, AI-driven rivals push into the same space.

Octamile helps insurance companies in Nigeria process claims faster by automating paperwork and approvals. The company has locked in some real advantages: it has government licenses and formal partnerships with local banks and delivery companies that would be hard for a newcomer to replicate overnight. But the company appears to be running low on cash (only $630K confirmed, with a claimed $2M round from late 2023 that was never publicly closed), and it has been completely quiet online for two years while better-funded competitors like Curacel and global AI insurance startups are aggressively moving into the same space. The one thing that could change everything is a confirmed new funding round and visible signs of hiring and new customer wins in 2025 or 2026; if the silence continues, the partnerships and licenses will not be enough to survive.

Why

AI pressure: Curacel and global AI-native insurtechs like Poetic and FurtherAI. Curacel already uses AI for claims and has Tencent backing; Poetic and FurtherAI are raising huge rounds for the same automation work Octamile does by hand. Could AI do the core job? Yes, likely.

Bigger players: AXA Mansard or FirstBank building embedded insurance in house. Octamile's own bank and insurer partners could absorb the tech and cut Octamile out, though no sign of this yet. Could a giant copy it? Probably.

What protects it. NAICOM licensing and existing embedded deals with Gokada, Treepz, FirstBank, and AXA Mansard give Octamile a real but shallow head start.

What would change this call

Public confirmation that Octamile's October 2023 $2M extension round closed. Shows whether Octamile secured capital needed to keep competing.
Curacel announces new bank, fintech, or mobility partnerships in Nigeria. Would show Curacel winning the embedded-insurance customers Octamile targets.
Octamile resumes public activity or announces shutdown/wind-down. Clarifies whether the two-year silence means stalling or quiet operation.

Key numbers

$630K total disclosed funding across 3 rounds (2023-06-21)
80,000+ policies distributed, 25% MoM growth (2023-10-01)
Rival Curacel has raised ~$5M with Tencent backing (2026-06-30)

Named risks

No confirmed funding, product, or headcount news for 2024 through mid-2026 suggests possible stall. Severity: high
Direct rival Curacel is materially better funded and Tencent-backed as of 2025. Severity: high
Core claims-automation workflows are the exact target of well-funded global AI-native entrants (2025-2026). Severity: high
No proprietary data moat evidenced beyond partner integrations, which are replicable by better-capitalized rivals. Severity: medium
Unconfirmed $2M extension round announced October 2023 may indicate a failed or stalled raise. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Curacel	losing to	YC W22, Tencent-backed, actively AI-powered claims automation as of Sept 2025 vs Octamile's 2.5-year public silence
Poetic	losing to	Raised $50M Series A with OpenAI as investor, June 2026, targeting same AI claims-automation workflows
FurtherAI	losing to	Raised $25M Series A in October 2025 for AI agents in insurance workflows
traditional insurers (AXA Mansard, FirstBank)	contesting	Currently partners, not rivals, but slow-moving incumbents could build in-house embedded insurance

Questions people ask

Is Octamile profitable in 2026?: No public revenue or profitability data exists for 2024 to 2026. The last self-reported figure was around $642,100 in revenue with a 10-person team in 2023, and no confirmed funding or product news has surfaced since October 2023.
Has Octamile raised its Series A yet?: As of mid-2026 there is no public confirmation. In October 2023 Octamile said it was targeting a $2 million extension raise after roughly $600,000 raised previously, but no close has been announced in the nearly three years since.
Who is Octamile's biggest competitor?: Curacel, a Lagos-based AI-powered claims automation startup founded in 2019 and a Y Combinator W22 graduate backed by Tencent, is Octamile's most frequently cited direct rival and appears better capitalized as of September 2025.
Could AI replace Octamile's claims processing business?: Octamile's core workflows, first notification of loss, document extraction, rules-based decisioning, and vehicle valuation, are exactly what AI-native rivals like Curacel and global players such as FurtherAI and Poetic are automating as of 2025 to 2026.
Who owns Octamile?: Octamile is a private, venture-backed Nigerian startup founded by CEO Gbenro Dara, a former Jumia, Hotels.ng, Cheki and Opera/OList executive, with no known parent company as of the most recent available data in 2023.
What licenses or partnerships give Octamile an edge in Nigeria?: Octamile holds NAICOM-related regulatory relationships and embedded partnerships with Gokada, Treepz, FirstBank and AXA Mansard, including an October 2023 Treepz Care insurance launch, giving it local integration lock-in that pure AI models lack.

Timeline

2023-10-16Treepz partnership launches Treepz Care insurance program for travelers and hosts
2023-10-01Octamile says it is raising $2M extension round; reports 80,000+ policies distributed, self-reported
2023-06-21Seed round of $130,000 closes with Norrsken Accelerator as investor (aggregator-sourced)
2022-03-09Seed VC round closes, amount undisclosed
2021-12-03Octamile raises $500,000 pre-seed led by EchoVC Partners, exits stealth mode
2019-09Company registration date per CB Insights, predating public 2021 launch

Revision history

23 July 2026

First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.

In the same band

Clearcover Huddle Insurance Bright Health Group

More in Insurance technology companies →

Sources